IONS
NASDAQ · Biotechnology
Ionis Pharmaceuticals Inc
$56.56
+2.07 (+3.80%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-33.29%
1Y
+35.83%
YTD
-29.01%
Open$54.73
Previous Close$54.49
Day High$56.60
Day Low$54.40
52W High$86.74
52W Low$40.03
Volume—
Avg Volume2.77M
Market Cap9.24B
P/E Ratio—
EPS$-3.47
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$80.92
Below
SMA 200
$60.03
Below
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
33 analysts
Price Target
+32.5% upside
Current
$56.56
$56.56
Target
$74.94
$74.94
$58.43
$74.94 avg
$113.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 963.31M | 822.50M | 6.52B |
| Net Income | -389,307,261 | -299,160,292 | -1,853,302,223 |
| Profit Margin | -40.4% | -38.4% | -28.4% |
| EBITDA | -379,392,870 | -307,738,410 | -2,518,216,651 |
| Free Cash Flow | — | — | -1,126,512,375 |
| Rev Growth | +17.1% | +17.1% | -9.9% |
| Debt/Equity | 4.77 | 4.77 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |